pre-exposure prophylaxis against HIV (Q7239230)

26 February 2016

1 reference

https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?linkID=RDS00107

Regulatory Decision Summary - TRUVADA (English)

United States of America

16 July 2012

1 reference

NDA 21752/S-030 (English)

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021752Orig1s030ltr.pdf

Belgium

1 June 2017

National Institute for Health and Disability Insurance

2 references

Geneesmiddel in PrEp om een HIV-infectie te voorkomen: terugbetaling vanaf 1 juni 2017 (Dutch)

https://www.inami.fgov.be/nl/themas/kost-terugbetaling/door-ziekenfonds/geneesmiddel-gezondheidsproduct/terugbetalen/specialiteiten/wijzigingen/Paginas/geneesmiddelen-PrEp-HIV.aspx

Lijst van de vergoedbare farmaceutische specialiteiten (Dutch)

Hoofdstuk IV, § 8750000

Portugal

1 reference

http://www.aidsmap.com/Belgium-Portugal-and-Brazil-will-provide-PrEP-through-their-health-services-Morocco-announces-a-PrEP-study/page/3144551/

Brazil

25 May 2017

1 reference

Portaria nº 21 de 25 maio de 2017 (Portuguese)

https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=29/05/2017&jornal=1&pagina=73&totalArquivos=132

Chile

1 reference

http://www.biobiochile.cl/noticias/nacional/chile/2017/08/08/truvada-la-pastilla-contra-el-vih-que-los-chilenos-compran-en-el-mercado-negro.shtml

France

1 January 2016

1 reference

https://www.liberation.fr/france/2016/07/21/sida-la-prep-a-portee-de-monde_1467735/

Scotland

10 April 2017

NHS Scotland

1 reference

Scottish Medicines Consortium

emtricitabine/tenofovir disoproxil (Truvada®) is accepted for use within NHS Scotland. (English)

author

https://www.scottishmedicines.org.uk/medicines-advice/emtricitabinetenofovir-disoproxil-truvada-fullsubmission-122517/

retrieved

29 December 2021

Norway

2 references

https://ecdc.europa.eu/sites/portal/files/documents/HIV%20and%20men%20who%20have%20sex%20with%20men.pdf

https://www.ecdc.europa.eu/sites/default/files/documents/HIV-Pre-Exposure-Prophylaxis-in-the-EU-EEA-UK.pdf

page(s)

Australia

2 May 2016

1 reference

https://www.tga.gov.au/node/732814

Australian Public Assessment Reportfor tenofovir disoproxil fumarate /emtricitabine (English)

Kenya

1 reference

https://www.hptn.org/resources/prevention

South Africa

1 reference

https://www.hptn.org/resources/prevention

Taiwan

1 reference

http://www.gilead.com/~/media/files/pdfs/other/preexposure%20prophylaxis%20082316.pdf?la=en

Peru

1 reference

http://www.gilead.com/~/media/files/pdfs/other/preexposure%20prophylaxis%20082316.pdf?la=en

Vietnam

1 reference

http://en.vietnamplus.vn/vietnam-strives-to-reduce-hiv-infections-despite-funds-shortage/116476.vnp

Israel

1 reference

http://www.mako.co.il/news-israel/health-q3_2017/Article-1c1c9ff155cbd51004.htm

New Zealand

1 reference

https://www.nzaf.org.nz/news-and-media/news/nzaf-welcomes-medsafes-milestone-decision-to-approve-truvada-for-pre-exposu/

Switzerland

https://www.swissmedic.ch/dam/swissmedic/de/dokumente/stab/journal/swissmedic-journal022020.pdf.download.pdf/Swissmedic%20Journal%2002-2020.pdf

27 February 2020

1 reference

3/2020

174

Germany

1 September 2019

National Health Insurance in Germany

2 references

SGB V

§ 20j

https://www.gesetze-im-internet.de/sgb_5/__20j.html

language of work or name

German

Q1006342

Anlage 33

https://www.kbv.de/media/sp/Anlage_33_HIV-Praeexpositionsprophylaxe.pdf

language of work or name

German

European Economic Area

18 August 2016

marketing authorization

3 references

Q2517574

Commission Regulation (EC) No 1234/2008

17(2)

20(7)(a)

Commission Implementing Decision of 18.8.2016 Amending the Marketing Authorisation Granted by Decision C(2005)456 for “truvada - Emtricitabine / Tenofovir Disoproxil Fumarate”, a Medicinal Product for Human Use (English)